DIRECT INTRAMYOCARDIAL TRANSTHORACIC TRANSPLANTATION OF BONE MARROW MONONUCLEAR CELLS FOR NON-ISCHEMIC DILATED CARDIOMYOPATHY: INTRACELL, A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Abstract

The trend of intragroup functional and subjective improvement was not confirmed when compared to the control group. Direct intramyocardial application of bone marrow mononuclear cells in non-ischemic dilated cardiomyopathy was not associated with significant changes in left ventricular function. Differences observed within the bone marrow mononuclear cells group could be due to placebo effect or low statistical power.